Systematic review shows that FDA's black box warnings on antidepressants may have led to reduced mental health care and increased youth suicide.

A systematic review published in Health Affairs indicates that the FDA's black box warnings on antidepressants, aimed at reducing youth suicidality, may have backfired. The study found declines in mental health care, fewer doctor visits for depression, and increases in psychotropic drug poisonings and suicide deaths among youth. Researchers recommend that the FDA reevaluate these warnings, suggesting they could be incorporated into routine warnings or removed entirely.

October 07, 2024
34 Articles

Further Reading